Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

President Trump Imposes 100% Tariffs on Imported Branded Drugs Starting Oct. 1

September 28, 2025

President Donald Trump announced a 100% import tariff on branded pharmaceutical drugs starting October 1, with exemptions for companies actively building manufacturing plants in the U.S. This...

Lonza’s Synaffix and Qurient Collaborate on Dual-Payload ADC Development

September 28, 2025

Lonza’s Synaffix platform is partnering with Qurient Therapeutics to develop a dual-payload antibody-drug conjugate (ADC) targeting solid tumors. This collaboration combines Synaffix’s...

CAR T Cell Therapy Targets Renal Cell Carcinoma with Off-the-Shelf Approach

September 28, 2025

Researchers are advancing chimeric antigen receptor (CAR) T cell therapies targeting CD70, highly expressed in over 80% of renal cell carcinomas (RCC) but limited in normal tissues. Efforts focus...

AI and Deep Learning Improve Medical Imaging and Clinical Phenotyping

September 28, 2025

Breakthroughs in artificial intelligence are enhancing diagnostics and clinical data interpretation. Ultromics reported improved early detection of cardiac amyloidosis through FDA-cleared AI...

Novel Protein Switches Enable Real-Time Precision Control of Therapeutics

September 28, 2025

University of Washington researchers introduced engineered protein switches that regulate therapeutic protein activity by controlling binding duration rather than affinity. This innovative...

Breakthroughs in Radiation Oncology Presented at ASTRO 2025

September 28, 2025

Leading cancer centers unveiled novel advances in radiation therapy. UCLA researchers highlighted targeted radioactive therapies, innovative stereotactic body radiation techniques (SBRT), and...

mRNA Vaccine Shows Promise for Age-Related Macular Degeneration in Animal Model

September 28, 2025

Scientists at the Institute of Science Tokyo developed a novel mRNA vaccine demonstrating efficacy in mitigating pathological neovascularization characteristic of age-related macular degeneration...

Crinetics’ Palsonify Secures FDA Nod for Acromegaly – New Oral Therapy Emerges

September 28, 2025

Crinetics Pharmaceuticals gained FDA approval for Palsonify (paltusotine), the first oral once-daily therapy to treat adult acromegaly patients who are either post-surgery inadequate responders or...

Trump’s 100% Tariff on Drug Imports Threatens Small Biotechs – Industry Faces New Challenges

September 28, 2025

President Donald Trump announced a 100% import tariff on branded pharmaceutical drugs starting October 1, with carve-outs for companies actively constructing manufacturing plants in the U.S. and...

Advanced AI and Robotics Forge Breakthroughs in Biomedical Engineering

September 28, 2025

Innovations in bioengineering are reshaping therapeutic delivery and diagnostics. Carnegie Mellon scientists developed biological microscale robots, "AggreBots," from human lung cells capable of...

Revolution in Cancer Treatment: Insights into Targeted Therapies and Molecular Mechanisms

September 28, 2025

Cutting-edge studies illuminate new frontiers in oncology. Glycan-dependent T cell recruiting (GlyTR) compounds designed at UC Irvine demonstrate pan-cancer immunotherapy efficacy by selectively...

New FDA Approvals and Breakthroughs in Oncology and Rare Diseases

September 28, 2025

Recent regulatory advancements fuel treatment options in oncology and rare diseases. Eli Lilly’s oral selective estrogen receptor degrader imlunestrant received FDA approval for late-stage,...

Breakthroughs in Genomic and Molecular Medicine Enhance Disease Understanding and Treatment

September 28, 2025

Recent research is unlocking complex genomic and molecular landscapes across diseases. New chromosome-level genome assemblies of vulnerable species like the Sichuan taimen provide key conservation...

Tech-Enabled Healthcare Boosts Diagnostics, AI, and Patient Support

September 28, 2025

Technological integration in healthcare accelerates innovation. Ultromics’ Echogo AI system advances cardiac amyloidosis diagnosis by improving early detection and reducing false positives. InfEHR...

Innovations in Organoid Technology and Regenerative Medicine

September 28, 2025

The NIH launched a $87 million Standardized Organoid Modeling Center to accelerate organoid research reproducibility, aiming to reduce reliance on animal testing. In parallel, artificial tissue...

Novel Drug Discovery and Development Advances with Collaborative Programs

September 28, 2025

Concept Life Sciences expanded its integrated drug discovery facilities in the U.K., consolidating chemistry, ADMET, and screening biology capabilities to streamline early-stage innovation....

New Technologies Enable Precision Agriculture and Environmental Solutions

September 28, 2025

Innovations offering sustainable agricultural and environmental impact solutions emerge prominently. Fully biodegradable hydrogels developed collaboratively by the Free University of Bozen-Bolzano...

Crinetics’ Palsonify Cleared: New Oral Treatment for Acromegaly Challenges Established Injectables

September 27, 2025

Crinetics Pharmaceuticals has secured FDA approval for Palsonify (paltusotine), the first once-daily oral therapy for acromegaly patients who are either ineligible for surgery or have inadequately...

Trump Threatens 100% Tariffs on Imported Pharma: Biotech Industry Faces Uncertainty

September 27, 2025

President Donald Trump announced a 100% tariff on branded pharmaceutical imports effective October 1, sparking widespread concern across the biotech industry. The administration indicated...

AI and Deep Learning Drive Diagnostic Advances in Cancer and Cardiology

September 27, 2025

Recent breakthroughs harness artificial intelligence to improve diagnostic accuracy in cancer and cardiovascular diseases. Researchers developed a deep learning model that enhances the...